Research location
Vienna
Austria, Austria
Advertisement
Research activity in Vienna
Austria, AustriaCureCurrent currently publishes aggregate city-level research activity for this location: 11 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Vienna
11 linked trials · page 1 of 1ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine ResponsivenessNCT07084558 · 2025-08-13 · 1 site observation
RECRUITING
The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of EmphysemaNCT06655428 · 2025-01-10 · 2 site observations
RECRUITING
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe EmphysemaNCT06035120 · 2024-02-22 · 1 site observation
RECRUITING
Retinal Neuro-vascular Coupling in Patients With Multiple SclerosisNCT03401879 · 2018-02-01 · 1 site observation
RECRUITING
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyNCT03394365 · 2017-12-29 · 1 site observation
RECRUITING
Stem Cell Ophthalmology Treatment Study IINCT03011541 · 2016-01-01 · 1 site observation
RECRUITING
Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal PolypsNCT07046117 · 2025-10-01 · 1 site observation
NOT_YET_RECRUITING
A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC PatientsNCT05676203 · 2023-05-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast CancerNCT02129556 · 2014-12-01 · 1 site observation
COMPLETED
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)NCT00549757 · 2007-10-01 · 1 site observation
TERMINATED
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast CancerNCT00248170 · 2005-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.